(Q40275257)

19 September 2017

title

Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein (English)

1 reference

19 September 2017

1 reference

3

Birke Bartosch

0 references

author name string

Tae-Hwe Heo

1

1 reference

19 September 2017

Song-Mi Lee

2

1 reference

19 September 2017

Birke Bartosch

3

1 reference

19 September 2017

François-Loïc Cosset

4

1 reference

19 September 2017

Chang-Yuil Kang

5

1 reference

19 September 2017

publication date

24 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

121

1 reference

19 September 2017

issue

1

1 reference

19 September 2017

page(s)

58-64

1 reference

Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Epidemiology of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Replication of hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

The tetraspanin CD81 is necessary for partitioning of coligated CD19/CD21-B cell antigen receptor complexes into signaling-active lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Association of the caveola vesicular system with cellular entry by filoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Incomplete humoral immunity against hepatitis C virus is linked with distinct recognition of putative multiple receptors by E2 envelope glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

DC-SIGN and L-SIGN are high affinity binding receptors for hepatitis C virus glycoprotein E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Characterization of functional hepatitis C virus envelope glycoproteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Structure-function analysis of hepatitis C virus envelope-CD81 binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Binding of hepatitis C virus to CD81

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. defining the rules for lipid traders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

CD81 is required for hepatitis C virus glycoprotein-mediated viral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2006.04.002

10.1016/J.VIRUSRES.2006.04.002

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference